Sign in to fuzzto save your conversations, follow your research and come back anytime.
Laxmi Dental
LAXMIDENTL
NSE
BSE
NSEBSESectorHealthcare
199.20
Loading chart…
NSEBSEThe Quarter story
The two most recent quarterly results, compared side-by-side.
Laxmi Dental rebounds with stronger margins and steady international growth after a mid-year slowdown.
Gross profit margin expands from 68.5% in Q2 FY26 to 78.6% in Q1 FY27, reflecting a stronger product mix.
Other operating expenses rise from ₹125.5 Cr in Q1 FY26 to ₹159.2 Cr in Q1 FY27, warning of rising overhead costs.
International laboratory revenue grows from ₹176 Cr in Q1 FY26 to ₹242 Cr in Q1 FY27, showing steady overseas demand.
Scanner sales revenue falls from ₹82 Cr in Q4 FY26 to ₹22 Cr in Q1 FY27, indicating weakening demand in this segment.
EBITDA margin recovers from 10.6% in Q3 FY26 to 19.2% in Q1 FY27, confirming improved operational efficiency.
Vedia aligner revenue rebounds from ₹73 Cr in Q4 FY26 to ₹118 Cr in Q1 FY27, signaling a successful product turnaround.
